Indicated for the reduction of atherosclerotic events (myocardial infarction, stroke and vascular death) in patients with atherosclerosis documented by recent stroke, recent myocardial infarction, or established peripheral arterial disease.
Información de Contacto
- Sitio Web:http://www.plavix.com/
En catálogos
Musharof Chy•21/02/2025•1 min de lectura•Actualizado hace 12 meses








